Top Markets
Coin of the day
LadRx Corporation LadRx Corporation

LadRx Corporation

LADX
Rank in Stocks #42092
LadRx Corporation, a biopharmaceutical company, engages in research and... LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States. The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the tumor. Its lead candidates comprising LADRs 7, 8, 9, and 10 with novel derivatives of the auristatin and maytansinoid drug targeting tumors; and aldoxorubicin, which is in phase II clinical development for the treatment of pancreatic cancer. In addition, the company develops albumin companion diagnostic (ACDx) to identify patients with cancer that benefits from treatment with the four LADR lead candidates. The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. The company was incorporated in 1985 and is headquartered in Los Angeles, California.
Share Price
$0.01
Last synced: 2026-07-20
Market Cap
$4.95K
Change (1 day)
0.00%
Change (1 year)
-98.46%
Country
US
Trade LadRx Corporation (LADX)

Category

Stock split history for LadRx Corporation (LADX)
LadRx Corporation stock (symbol: LADX) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 13, 2026.
One LADX share bought prior to Aug 13, 2026 would equal to 0 LADX shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR